UBS Maintains Neutral on Nuveen Churchill Direct, Lowers Price Target to $14.75

UBS analyst Doug Harter maintains Nuveen Churchill Direct (NYSE:NCDL) with a Neutral and lowers the price target from $15.5 to $14.75.